Bloomios

Bloomios Earnings Yield

The Earnings Yield of Bloomios (BLMS) as of Nov 1, 2026 is -396,088.70 %. In the previous year, Earnings Yield was -137,740.00 % — a change of 187.56% (lower).

Earnings Yield

-396,088.70 %

YoY

187.56%

Last updated:

Earnings Yield of Bloomios is 2023 -396,088.70 % . Earnings Yield of Bloomios was 2022 -137,740.00 % . It decreases by 187.56% lower compared to the previous year.

The Bloomios Earnings Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Earnings Yield
Date
Earnings Yield
Jan 1, 2018
-100.00 USD
Jan 1, 2019
-4,902.34 USD
Jan 1, 2020
-168.63 USD
Jan 1, 2021
-20,110.00 USD
Jan 1, 2022
-137,740.00 USD
Jan 1, 2023
-396,088.70 USD
The Bloomios Earnings Yield history
YEAREarnings YieldYoY
-396,088.70 %+187.56%
-137,740.00 %+584.93%
-20,110.00 %+11,825.52%
-168.63 %-96.56%
-4,902.34 %+4,802.34%
-100.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bloomios Stock analysis

What does Bloomios do? Bloomios, Inc. generates revenue through the wholesale distribution of U.S. hemp-derived supplements and cosmetic products. The company manufactures and distributes hemp-infused edibles, pet edibles, tinctures, shots, topicals, smokable hemp, and other products across seven categories including edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. BPL, a subsidiary of Bloomios, focuses on manufacturing and distributing hemp-derived nootropic and nutraceutical products to wholesalers and retailers. Bloomios provides private-label and white-label services with over 80 customizable products and custom formulation and manufacturing support for its customers. The company's primary customers are wholesalers and retailers who purchase its hemp-derived products for resale. Bloomios offers a comprehensive suite of services including custom formulation, order fulfillment, and brand development to support its clients. Its product portfolio spans multiple categories such as human edibles, pet edibles, liquid consumables, topicals, and smokable hemp, catering to both consumer and pet markets. Bloomios leverages its subsidiary BPL to expand its product offerings in the hemp-derived nootropic and nutraceutical sectors. The company's focus on customizable solutions allows it to serve a diverse range of clients seeking private-label and white-label hemp products. Through its wholesale distribution channels, Bloomios targets businesses looking to sell hemp-based supplements and cosmetics under their own brand names. Bloomios is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bloomios stock

Earnings Yield of Bloomios is -396,088.70 % in 2023.

Earnings Yield of Bloomios changed from -137,740.00 % to -396,088.70 %, representing a 187.56% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield Bloomios since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's Bloomios with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Bloomios

All Key Metrics — Bloomios